مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
Click here for full text options
LibKey Link

مصطلحات الفهرس: article, Australia, cancer patient, cancer radiotherapy, castration resistant prostate cancer/di [Diagnosis], castration resistant prostate cancer/dt [Drug Therapy], castration resistant prostate cancer/rt [Radiotherapy], castration resistant prostate cancer/th [Therapy], clinical effectiveness, community hospital, controlled study, drug activity, drug efficacy, human, major clinical study, metastasis/dt [Drug Therapy], metastasis potential, multiple cycle treatment, priority journal, prospective study, retrospective study, time to treatment, treatment failure, treatment outcome, treatment response time, university hospital, very elderly, abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], androgen receptor antagonist/cm [Drug Comparison], androgen receptor antagonist/dt [Drug Therapy], cabazitaxel/dt [Drug Therapy], cabazitaxel/pv [Special Situation for Pharmacovigilance], carboplatin/dt [Drug Therapy], carboplatin/pv [Special Situation for Pharmacovigilance], docetaxel/cm [Drug Comparison], docetaxel/dt [Drug Therapy], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], prostate specific antigen/ec [Endogenous Compound], metastatic hormone sensitive prostate cancer/dt [Drug Therapy], adult, confidence interval, androgen deprivation therapy, aged, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27351Test
Asia-Pacific Journal of Clinical Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
LibKey Link

مصطلحات الفهرس: article, Australia, cancer patient, cancer radiotherapy, castration resistant prostate cancer/di [Diagnosis], castration resistant prostate cancer/dt [Drug Therapy], castration resistant prostate cancer/rt [Radiotherapy], castration resistant prostate cancer/th [Therapy], clinical effectiveness, community hospital, controlled study, drug activity, drug efficacy, human, major clinical study, metastasis/dt [Drug Therapy], metastasis potential, multiple cycle treatment, priority journal, prospective study, retrospective study, time to treatment, treatment failure, treatment outcome, treatment response time, university hospital, very elderly, abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], androgen receptor antagonist/cm [Drug Comparison], androgen receptor antagonist/dt [Drug Therapy], cabazitaxel/dt [Drug Therapy], cabazitaxel/pv [Special Situation for Pharmacovigilance], carboplatin/dt [Drug Therapy], carboplatin/pv [Special Situation for Pharmacovigilance], docetaxel/cm [Drug Comparison], docetaxel/dt [Drug Therapy], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], prostate specific antigen/ec [Endogenous Compound], metastatic hormone sensitive prostate cancer/dt [Drug Therapy], adult, confidence interval, androgen deprivation therapy, aged, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27351Test
Asia-Pacific Journal of Clinical Oncology
LibKey Link

مصطلحات الفهرس: cancer radiotherapy, castration resistant prostate cancer/di [Diagnosis], castration resistant prostate cancer/dt [Drug Therapy], castration resistant prostate cancer/rt [Radiotherapy], clinical outcome, cohort analysis, copy number variation, DNA fingerprinting, follow up, gene expression, hazard ratio, high throughput sequencing, human, Kaplan Meier method, liquid biopsy, male, middle aged, overall survival, priority journal, progression free survival, proportional hazards model, prospective study, RNA fingerprinting, somatic mutation, validation study, very elderly, abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], androgen receptor/ec [Endogenous Compound], androgen receptor antagonist/dt [Drug Therapy], androgen receptor antagonist/pv [Special Situation for Pharmacovigilance], cabazitaxel/dt [Drug Therapy], cabazitaxel/pv [Special Situation for Pharmacovigilance], cell free nucleic acid/ec [Endogenous Compound], docetaxel/dt [Drug Therapy], docetaxel/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], prostate specific antigen/ec [Endogenous Compound], taxane derivative/dt [Drug Therapy], taxane derivative/pv [Special Situation for Pharmacovigilance], major clinical study, adult, aged, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29172Test
European Urology
Click here for full text options
LibKey Link

مصطلحات الفهرس: cancer radiotherapy, castration resistant prostate cancer/di [Diagnosis], castration resistant prostate cancer/dt [Drug Therapy], castration resistant prostate cancer/rt [Radiotherapy], clinical outcome, cohort analysis, copy number variation, DNA fingerprinting, follow up, gene expression, hazard ratio, high throughput sequencing, human, Kaplan Meier method, liquid biopsy, male, middle aged, overall survival, priority journal, progression free survival, proportional hazards model, prospective study, RNA fingerprinting, somatic mutation, validation study, very elderly, abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], androgen receptor/ec [Endogenous Compound], androgen receptor antagonist/dt [Drug Therapy], androgen receptor antagonist/pv [Special Situation for Pharmacovigilance], cabazitaxel/dt [Drug Therapy], cabazitaxel/pv [Special Situation for Pharmacovigilance], cell free nucleic acid/ec [Endogenous Compound], docetaxel/dt [Drug Therapy], docetaxel/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], prostate specific antigen/ec [Endogenous Compound], taxane derivative/dt [Drug Therapy], taxane derivative/pv [Special Situation for Pharmacovigilance], major clinical study, adult, aged, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29172Test
European Urology
LibKey Link

مصطلحات الفهرس: docetaxel/ct [Clinical Trial], docetaxel/cb [Drug Combination], docetaxel/dt [Drug Therapy], docetaxel/pv [Special Situation for Pharmacovigilance], enzalutamide/ae [Adverse Drug Reaction], enzalutamide/ct [Clinical Trial], enzalutamide/cb [Drug Combination], enzalutamide/dt [Drug Therapy], enzalutamide/tm [Unexpected Outcome of Drug Treatment], prostate specific antigen/ec [Endogenous Compound], testosterone, enzalutamide/pv [Special Situation for Pharmacovigilance], sensory neuropathy/si [Side Effect], side effect/si [Side Effect], acute coronary syndrome/si [Side Effect], aged, anemia/si [Side Effect], article, cancer chemotherapy, cancer patient, cancer survival, cerebrovascular accident/si [Side Effect], controlled study, delirium/si [Side Effect], drug withdrawal, faintness/si [Side Effect], falling, fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], follow up, health care quality, heart infarction/si [Side Effect], human, hypertension/si [Side Effect], major clinical study, male, metastasis, mortality, neutrophil count, overall survival, peripheral neuropathy/si [Side Effect], phase 3 clinical trial, priority journal, progression free survival, prostate cancer/dt [Drug Therapy], randomized controlled trial, seizure/si [Side Effect], thorax pain/si [Side Effect], thromboembolism/si [Side Effect], treatment withdrawal, antiandrogen/ae [Adverse Drug Reaction], antiandrogen/ct [Clinical Trial], antiandrogen/cb [Drug Combination], antiandrogen/dt [Drug Therapy], antiandrogen/pv [Special Situation for Pharmacovigilance], docetaxel/ae [Adverse Drug Reaction], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35581Test
New England Journal of Medicine
Click here for full text options
LibKey Link

مصطلحات الفهرس: docetaxel/ct [Clinical Trial], docetaxel/cb [Drug Combination], docetaxel/dt [Drug Therapy], docetaxel/pv [Special Situation for Pharmacovigilance], enzalutamide/ae [Adverse Drug Reaction], enzalutamide/ct [Clinical Trial], enzalutamide/cb [Drug Combination], enzalutamide/dt [Drug Therapy], enzalutamide/tm [Unexpected Outcome of Drug Treatment], prostate specific antigen/ec [Endogenous Compound], testosterone, enzalutamide/pv [Special Situation for Pharmacovigilance], sensory neuropathy/si [Side Effect], side effect/si [Side Effect], acute coronary syndrome/si [Side Effect], aged, anemia/si [Side Effect], article, cancer chemotherapy, cancer patient, cancer survival, cerebrovascular accident/si [Side Effect], controlled study, delirium/si [Side Effect], drug withdrawal, faintness/si [Side Effect], falling, fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], follow up, health care quality, heart infarction/si [Side Effect], human, hypertension/si [Side Effect], major clinical study, male, metastasis, mortality, neutrophil count, overall survival, peripheral neuropathy/si [Side Effect], phase 3 clinical trial, priority journal, progression free survival, prostate cancer/dt [Drug Therapy], randomized controlled trial, seizure/si [Side Effect], thorax pain/si [Side Effect], thromboembolism/si [Side Effect], treatment withdrawal, antiandrogen/ae [Adverse Drug Reaction], antiandrogen/ct [Clinical Trial], antiandrogen/cb [Drug Combination], antiandrogen/dt [Drug Therapy], antiandrogen/pv [Special Situation for Pharmacovigilance], docetaxel/ae [Adverse Drug Reaction], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35581Test
New England Journal of Medicine
LibKey Link

مصطلحات الفهرس: risk assessment, adult, aged, article, blood sampling, cancer prognosis, castration resistant prostate cancer/dt [Drug Therapy], clinical outcome, cohort analysis, follow up, gene, gene expression, human, male, outcome assessment, overall survival, prospective study, reverse transcription polymerase chain reaction, survival analysis, abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], androgen receptor, cabazitaxel/dt [Drug Therapy], cabazitaxel/pv [Special Situation for Pharmacovigilance], carboplatin/dt [Drug Therapy], carboplatin/pv [Special Situation for Pharmacovigilance], docetaxel/dt [Drug Therapy], docetaxel/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], Foxa1 gene, GRHL2 gene, hoxb13 gene, Pax gene, cancer patient, castration resistant prostate cancer, chemotherapy, prognosis, stratification, systemic therapy, biological marker, endogenous compound, Article

URL: Click here for full text options
LibKey Link

مصطلحات الفهرس: risk assessment, adult, aged, article, blood sampling, cancer prognosis, castration resistant prostate cancer/dt [Drug Therapy], clinical outcome, cohort analysis, follow up, gene, gene expression, human, male, outcome assessment, overall survival, prospective study, reverse transcription polymerase chain reaction, survival analysis, abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], androgen receptor, cabazitaxel/dt [Drug Therapy], cabazitaxel/pv [Special Situation for Pharmacovigilance], carboplatin/dt [Drug Therapy], carboplatin/pv [Special Situation for Pharmacovigilance], docetaxel/dt [Drug Therapy], docetaxel/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], Foxa1 gene, GRHL2 gene, hoxb13 gene, Pax gene, cancer patient, castration resistant prostate cancer, chemotherapy, prognosis, stratification, systemic therapy, biological marker, endogenous compound, Article

URL: Click here for full text options
LibKey Link